ResearcherSapporo Medical UniversityActive in the last 2 years

Joji Muramatsu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7711-5450; OpenAlex author ID A5007697217. Sources: OpenAlex.

Their work

Papers: 3 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 2 papers · 2025: none · 2026: 1 paper

Papers 3

Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy: A retrospective multice… First author DOI 10.21203/rs.3.rs-9156519/v1 ↗
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. First author DOI 10.1093/jjco/hyad131 ↗
Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. Co-author DOI 10.1111/cas.16101 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kohichi Takada · 3 shared papers, 2024–2026 · strength 0.63
Makoto Yoshida · 2 shared papers, 2024–2026 · strength 0.44
- Paper Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuva… DOI 10.21203/rs.3.rs-9156519/v1 ↗
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131 ↗
Tomohiro Kubo · 2 shared papers, 2024 · strength 0.36
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101 ↗
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131 ↗
Masafumi Imamura · 1 shared paper, 2026 · strength 0.26
- Paper Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuva… DOI 10.21203/rs.3.rs-9156519/v1 ↗
Takashi Kojima · 1 shared paper, 2024 · strength 0.19
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101 ↗
Takumi Konno · 1 shared paper, 2024 · strength 0.19
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101 ↗
Masayoshi Kobune · 1 shared paper, 2024 · strength 0.19
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101 ↗
Makoto Yoshida · 1 shared paper, 2024 · strength 0.19
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101 ↗
Makoto Usami · 1 shared paper, 2024 · strength 0.17
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131 ↗
Yuki Ikeda · 1 shared paper, 2024 · strength 0.17
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.